Genmab — Marts 2017
-
https://pbs.twimg.com/media/C56DUeSUwAEoQDk?format=jpg&name=large Prøver denne, der viser at dara
giver 3 gange så mange mdr negative resondrre -
https://pbs.twimg.com/media/C56EdkEUwAAoH-n?format=jpg&name=large Ingen tilbagefald i high risk mrd negative respondre. Imponerende.
-
Den er også med i Usmanis ash-update http://files.shareholder.com/downloads/AMDA-KPIBN/3941747003x0x920041/3403AF4D-1CE1-4EEC-AD89-C2ACAD47C493/Usmani_POLLUX_prior_line_ASH_2016_slides_FINAL.pdf slide 6
-
Karyopharm Follows Juno With Leukemia Drug Dud; Stock Topples
Karyopharm stock toppled Friday after its lead drug flunked a leukemia trial, though Leerink sees promise in other cancers.
Investor's Business Daily (www.investors.com)
-
Carina måske på EHA?
-
hvad er forklaringen egentlig på, at Carina først skulle komme Q4 i 16, så Q1 i 2017 og nu er vi i H2 2017??
-
Ved ikke?
-
God morgen.

-
GB 24/2 11.23 skrev du: "Nyheder fra Carina, Alcyone og tisotumab kommer alle i andet halvår". Jeg er ikke i stand til at henvise til noget konkret ang Carina. Mente bare, at det var konsensus med H2 her i chatten. Tilsyneladende har du haft samme opfattelse?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind